GlassScriptPhysician profile
Ashley Kelly
NPI 1386105476
$1,891.31
in general payments reported to CMS, 2019-2025
16 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.69 · 2023: $764 · 2024: $614 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.64 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $327.17 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $208.10 | 2023-2025 | Caplyta |
| Alkermes, INC. | $154.10 | 2023-2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $131.61 | 2022-2025 | Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $59.23 | 2023-2024 | Ingrezza |
| Tris Pharma INC | $56.10 | 2023-2024 | Dyanavel Xr |
| Corium, LLC | $53.60 | 2023 | Azstarys |
| Axsome Therapeutics, INC. | $52.10 | 2024 | Auvelity |
| Idorsia Pharmaceuticals US INC | $47.95 | 2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $45.82 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.05 | 2024-2025 | Trintellix |
| Biogen, INC. | $35.73 | 2025 | Zurzuvae |
| Astrazeneca Pharmaceuticals LP | $30.93 | 2025 | Airsupra |
| Almatica Pharma LLC | $13.84 | 2023 | Gralise |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tms Neurohealth Centers INC. | $9.34 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.